Trial Profile
Comparing Abatacept to Adalimumab, Etanercept and Infliximab As First Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Adalimumab; Etanercept; Infliximab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 27 Aug 2015 New trial record